Atlas Trials

A Study of Concomitant Camrelizumab With Chemoradiation for Locally Advanced Head and Neck Cancer

Clinical trial NCT04405154 · UNKNOWN

Trial details

NCT number
NCT04405154
Sponsor
West China Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck Neoplasms
Start date
2020-06-01
Primary completion
2023-05-31
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.